Genetically Modified Salmon on the Market?

A biotech company is hoping to cash in on a genetically modified salmon. If the F-D-A approves the fish, it would be the first transgenic animal species available for human consumption. The Great Lake Radio Consortium’s Nancy Cohen reports:

Transcript

A biotech company is hoping to cash in on a genetically modified
salmon. If the FDA approves the fish, it would be the first transgenic
animal species available for human consumption. The Great Lake Radio
Consortium’s Nancy Cohen reports:


Aquaculture firms are developing fish that are resistant to disease,
consume low-cost diets and grow faster. The Massachusetts-based Aqua
Bounty Technologies took part of the genetic code from a fish called the
ocean pout, and added it to the Atlantic salmon. The ocean pout’s
genetic material acts as a kind of switch that turns on the salmon’s
growth regulators.


Joe McGonigle is with Aqua Bounty. He says the result is a salmon that
grows twice as fast as other farmed salmon.


“You can get more heart healthy omega 3 protein on the market at a
lower price, you can produce fish more quickly, you can use fewer
resources and you can manage water quality and fish health, in a much
better way than under current conditions.”


But critics are concerned about the environmental impact on native fish
populations if genetically modified fish were to escape into the wild.


For the GLRC, I’m Nancy Cohen.

Related Links

Biotech Companies Agree to Regional Moratorium

Several biotech companies have agreed not to grow genetically modified crops in Corn Belt states, including Ohio, Indiana, Illinois, Missouri, parts of Kentucky, parts of Nebraska, and Minnesota. The Great Lakes Radio Consortium’s Natalie Walston reports:

Transcript

Several biotech companies have agreed not to grow genetically modified crops in Corn
Belt states, including Ohio, Indiana, Illinois, Missouri, parts of Kentucky, parts of
Nebraska, and Minnesota. The Great Lakes Radio Consortium’s Natalie Walston reports:


Twelve biotech companies including Monsanto and Dow agreed to the moratorium. In
states where the corn might contaminate nearby fields planted with crops for human
consumption.


Lisa dry is with the Biotechnology Industry Organization in Washington, D.C.
She says the companies won’t grow corn and safflower used for medicines.


“This is pharmaceutical production, it is not agricultural or food production. We are
taking every single possible precaution to make sure that it stays in its intended use
channel and does not end up in the food or feed.”


Dry says commercial grocers, exporters, and food processors have been concerned about
the Starlink scandal of 2000, when genetically modified corn approved for animal feed
turned up in 300 varieties of taco shells, tostadas and chips. The biotech companies say
they will grow crops in non-traditional areas such as Hawaii, Arizona, and Puerto Rico.


For the Great Lakes Radio Consortium, I’m Natalie Walston.